Defence

Shares of UnitedHealth Group Incorporated (NYSE:UNH) are being sold by CFO4Life Group LLC


CFO4Life Group LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNHGet a rating) by 2.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,579 shares of the healthcare conglomerate’s stock after selling 105 shares during the quarter. CFO4Life Group LLC’s holdings in UnitedHealth Group were worth $1,859,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of UNH. Advocacy Wealth Management Services LLC raised its stake in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares during the period. Cascade Investment Advisors Inc. grew its position in UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares during the period. Rothschild & Co Wealth Management UK Ltd purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $31,000. Rise Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at $38,000. Finally, Evolution Advisers Inc. acquired a new stake in UnitedHealth Group during the 1st quarter worth about $38,000. Institutional investors and hedge funds own 87.25% of the company’s shares.

UnitedHealth Group trade fell 0.7%

NYSE:UNH opened at $505.04 on Friday. The company has a current ratio of 0.77, a gearing ratio of 0.77, and a debt-to-equity ratio of 0.60. The 50 day simple moving average is $528.35 and the 200 day simple moving average is $513.52. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The firm has a market cap of $472.40 billion, a P/E ratio of 26.37, a PEG ratio of 1.59 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet a rating) last published its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company’s revenue grew by 12.6% compared to the same period last year. During the same quarter last year, the business earned $4.70 per share. equities analysts anticipate that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a dividend of $1.65 per share. This represents an annualized dividend of $6.60 and a yield of 1.31%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insider buying and selling at UnitedHealth Group

In other SAO news Thomas E. Roos sold 465 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37 for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a legal filing with the Securities and Exchange Commission, which is available through SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37 for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was announced in a filing with the SEC, which is available at this link. In addition, the general manager Dirk S. McMahon sold 14,715 shares of the company’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $543.32 for a total value of $7,994,953.80. Following the completion of the sale, the chief executive officer now owns 50,108 shares in the company, valued at approximately $27,224,678.56. Disclosures for this sale can be found here here. Insiders sold 139,051 shares of company stock valued at $74,450,958 over the last quarter. 0.40% of shares are owned by company insiders.

Wall Street analysts predict growth

UNH has been the subject of a number of recent research reports. Loop Capital began coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective on the stock. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. SVB Leerink boosted their target price on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. Finally, Argus upped their target price on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research note on Monday, July 25th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. The company presently has an average rating of “Moderate Buy” and a consensus price target of $586.40, according to MarketBeat.

About UnitedHealth Group

(Get a rating)

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health care plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and wellness services for people age 50 and older that meet their needs for preventive and emergency health care, as well as services related to chronic diseases and other specialized problems for older adults; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)



Get UnitedHealth Group news and ratings daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies MarketBeat.com’s FREE Daily E-Newsletter.

https://www.defenseworld.net/2022/10/02/unitedhealth-group-incorporated-nyseunh-shares-sold-by-cfo4life-group-llc.html Shares of UnitedHealth Group Incorporated (NYSE:UNH) are being sold by CFO4Life Group LLC

Back to top button